BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

39 related articles for article (PubMed ID: 22121160)

  • 1. Correction to "Random control selection for conducting high-throughput adverse drug events screening using large-scale longitudinal health data".
    CPT Pharmacometrics Syst Pharmacol; 2024 Jun; ():. PubMed ID: 38938014
    [No Abstract]   [Full Text] [Related]  

  • 2. Increasing the Content of High-Content Screening: An Overview.
    Singh S; Carpenter AE; Genovesio A
    J Biomol Screen; 2014 Jun; 19(5):640-50. PubMed ID: 24710339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A statistical framework for high-content phenotypic profiling using cellular feature distributions.
    Pearson YE; Kremb S; Butterfoss GL; Xie X; Fahs H; Gunsalus KC
    Commun Biol; 2022 Dec; 5(1):1409. PubMed ID: 36550289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy.
    Allan KJ; Mahoney DJ; Baird SD; Lefebvre CA; Stojdl DF
    J Vis Exp; 2018 Apr; (134):. PubMed ID: 29683442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and correction of spatial bias are essential for obtaining quality data in high-throughput screening technologies.
    Mazoure B; Nadon R; Makarenkov V
    Sci Rep; 2017 Sep; 7(1):11921. PubMed ID: 28931934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Temperature gradients drive radial fluid flow in Petri dishes and multiwell plates.
    Lindsay SM; Yin J
    AIChE J; 2016 Jun; 62(6):2227-2233. PubMed ID: 27158150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Viability assays for cells in culture.
    Posimo JM; Unnithan AS; Gleixner AM; Choi HJ; Jiang Y; Pulugulla SH; Leak RK
    J Vis Exp; 2014 Jan; (83):e50645. PubMed ID: 24472892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SbacHTS: spatial background noise correction for high-throughput RNAi screening.
    Zhong R; Kim MS; White MA; Xie Y; Xiao G
    Bioinformatics; 2013 Sep; 29(17):2218-20. PubMed ID: 23814141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GUItars: a GUI tool for analysis of high-throughput RNA interference screening data.
    Goktug AN; Ong SS; Chen T
    PLoS One; 2012; 7(11):e49386. PubMed ID: 23185323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A simple method for analyzing actives in random RNAi screens: introducing the "H Score" for hit nomination & gene prioritization.
    Bhinder B; Djaballah H
    Comb Chem High Throughput Screen; 2012 Nov; 15(9):686-704. PubMed ID: 22934950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An Automatic Quality Control Pipeline for High-Throughput Screening Hit Identification.
    Zhai Y; Chen K; Zhong Y; Zhou B; Ainscow E; Wu YT; Zhou Y
    J Biomol Screen; 2016 Sep; 21(8):832-41. PubMed ID: 27313114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detecting and overcoming systematic bias in high-throughput screening technologies: a comprehensive review of practical issues and methodological solutions.
    Caraus I; Alsuwailem AA; Nadon R; Makarenkov V
    Brief Bioinform; 2015 Nov; 16(6):974-86. PubMed ID: 25750417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and validation of siRNAs and shRNAs.
    Tilesi F; Fradiani P; Socci V; Willems D; Ascenzioni F
    Curr Opin Mol Ther; 2009 Apr; 11(2):156-64. PubMed ID: 19330721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel specific edge effect correction method for RNA interference screenings.
    Carralot JP; Ogier A; Boese A; Genovesio A; Brodin P; Sommer P; Dorval T
    Bioinformatics; 2012 Jan; 28(2):261-8. PubMed ID: 22121160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Robust statistical methods for hit selection in RNA interference high-throughput screening experiments.
    Zhang XD; Yang XC; Chung N; Gates A; Stec E; Kunapuli P; Holder DJ; Ferrer M; Espeseth AS
    Pharmacogenomics; 2006 Apr; 7(3):299-309. PubMed ID: 16610941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of normalization methods on high-throughput screening data with high hit rates and drug testing with dose-response data.
    Mpindi JP; Swapnil P; Dmitrii B; Jani S; Saeed K; Wennerberg K; Aittokallio T; Östling P; Kallioniemi O
    Bioinformatics; 2015 Dec; 31(23):3815-21. PubMed ID: 26254433
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.